Author(s): G. Raveendra Babu, M. Sowjanya, M. Ramayyappa, Md. Abdul Karishma, V. Bharathi, G. Renuka Swathi, Ch. Renuka, G. Gopala Krishna, M. Lavanya

Email(s): upendragudimetla@gmail.com

DOI: 10.52711/0974-360X.2023.00170   

Address: G. Raveendra Babu1,2*, M. Sowjanya3, M. Ramayyappa2, Md. Abdul Karishma2, V. Bharathi2, G. Renuka Swathi2, Ch. Renuka2, G. Gopala Krishna2, M. Lavanya2
1Department of Pharmaceutical Analysis, QIS College of Pharmacy, Ongole - 523001, A.P., India.
2Department of Pharmaceutical Analysis, A.K.R.G. College of Pharmacy, Nallajerla - 534112, A.P., India.
3Department of Chemistry, Vijaya Teja Degree College, Addanki - 523201, A.P., India.
*Corresponding Author

Published In:   Volume - 16,      Issue - 3,     Year - 2023


ABSTRACT:
A simple, precise, accurate method was developed for the estimation of Umeclidinium andVilanterol in human plasma using Empagliflozin as internal standard by RP-HPLC (Reverse phase-High performance Liquid Chromatographic) technique. Chromatographic conditions used are stationary phase KromasilC18 (250 x 4.6 mm, 5m)coulmn, mobile phase of 0.01N di sodium hydrogen phosphate (pH: 3.0): Acetonitrile in the ratio of 65:35(v/v) and flow rate was maintained at 1.0ml/min, detection wave length was 215nm, column temperature was set at 30oC and diluent was mobile phase. Retention time of Umeclidinium and Vilanterol and were found to be 2.471min and 3.303min. %CV of the Umeclidinium and Vilanterol were found to be 0.33% and 0.43%. %Recovery was obtained as 99.34% and 99.029%. The linearity concentration is in the range of 1.25-50µg/mL of Umeclidinium, 0.25-10.0µg/mL of Vilanterol respectively. The lower limits of quantification were 1.25µg/mL of Umeclidiniumand 0.25µg/mL of Vilanterol which reach the level of both drugs possibly found in human plasma. Further, the reported method was validated as per the ICH guidelines and found to be well within the acceptable range.


Cite this article:
G. Raveendra Babu, M. Sowjanya, M. Ramayyappa, Md. Abdul Karishma, V. Bharathi, G. Renuka Swathi, Ch. Renuka, G. Gopala Krishna, M. Lavanya. Rapid RP-HPLC Method for Simultaneous estimation of Umeclidinium and Vilanterol in human plasma. Research Journal of Pharmacy and Technology 2023; 16(3):1017-2. doi: 10.52711/0974-360X.2023.00170

Cite(Electronic):
G. Raveendra Babu, M. Sowjanya, M. Ramayyappa, Md. Abdul Karishma, V. Bharathi, G. Renuka Swathi, Ch. Renuka, G. Gopala Krishna, M. Lavanya. Rapid RP-HPLC Method for Simultaneous estimation of Umeclidinium and Vilanterol in human plasma. Research Journal of Pharmacy and Technology 2023; 16(3):1017-2. doi: 10.52711/0974-360X.2023.00170   Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-3-6


REFERENCES:
1.    https://pubchem.ncbi.nlm.nih.gov/compound/Umeclidinium Accessed on 22-05-2022.
2.    https://pubchem.ncbi.nlm.nih.gov/compound/Vilanterol.Accessed on 22-05-2022.
3.    https://www.rxlist.com/anoro-ellipta-drug.htm.Accessed on 22-05-2022.
4.    Allen A, Schenkenberger I, Trivedi R, et al. Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study. ClinRespir J. 2013;7(4):397-406. doi:10.1111/crj.12026
5.    Harrell AW, Siederer SK, Bal J, et al. Metabolism and disposition of vilanterol, a long-acting β(2)-adrenoceptor agonist for inhalation use in humans. Drug MetabDispos. 2013;41(1):89-100. doi:10.1124/dmd.112.048603
6.    Spyratos D, Sichletidis L. Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review. TherClin Risk Manag. 2015 Mar 25;11:481-7. doi: 10.2147/TCRM.S67491. PMID: 25848294; PMCID: PMC4378877.
7.    Masimukku, Chintala. Development and validation of spectrophotometric methods for simultaneous estimation of vilanterol and fluticasone furoate in pharmaceutical formulations. Asian J Pharm Clin Res. 2017;10(4): 302-305.https://doi.org/10.22159/ajpcr.2017.v10i4.16748
8.    Patel D, Namdev KK, Verma K, et al. HPLC-UV and spectrofluorimetric methods for simultaneous estimation of fluticasone furoate and vilanterol in rabbit plasma: A pharmacokinetic study. Journal of chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 2019; 1132:1218.doi:: 10.1016/j.jchromb.2019.121842.
9.    Shiv Kumar Gupta, Babita Kumar, Pramod Kumar Sharma. Development and validation of a Spectrophometric method for estimation of Triamcinolone in solid dosage form. Asian J. Pharm. Ana. 2013;3(2):42-43.https://ajpaonline.com/AbstractView.aspx?PID=2013-3-2-2
10.    G. RaveendraBabu, J. SrinivasaRao, K. Suresh kumar, P. Jayachandra Reddy. Stability Indicating Liquid Chromatographic Method for Aripiprazole. Asian J. Pharm. Ana. 2011; 1(1): 03-07.https://ajpaonline.com/AbstractView.aspx?PID=2011-1-1-2
11.    Akhilesh Gupta, Swati Rawat, Mayuri Gandhi, Jaydeep Singh Yadav. Method Development and Acid Degradation Study of Doxofylline by RP-HPLC and LC-MS/MS. Asian J. Pharm. Ana. 2011;1(1): 10-13.https://ajpaonline.com/AbstractView.aspx?PID=2011-1-1-4
12.    Md. AhsanulHaque, Mohammad Shahriar, Most. NazmaParvin, S. M. Ashraful Islam. Validated RP-HPLC Method for Estimation of Ranitidine Hydrochloride, Domperidone and Naproxen in Solid Dosage Form. Asian J. Pharm. Ana.2011; 1(3): 59-63.https://ajpaonline.com/AbstractView.aspx?PID=2011-1-3-6
13.    A. Thenmozhi, D. Sridharan, S. Veeramani , M. Palanivelu.. An RP-HPLC Method for the estimation of Dexibuprofen in Pharmaceutical Tablet Dosage Form. Asian J. Pharm. Ana. 2011;1(4): 98-99.doi:10.5958/2231–5675
14.    Sharmin Reza Chowdhury, MahfuzaMaleque, MahbubulHoqueShihan. Development and Validation of a Simple RP-HPLC Method for Determination of Caffeine in Pharmaceutical Dosage Forms. Asian J. Pharm. Ana. 2012;2(1): 01-04.doi: 10.5958/2231–5675
15.    Analytical Method Development and Method Validation for the Simultaneous Estimation of Metformin hydrochloride and Pioglitazone hydrochloride in Tablet Dosage Form by RP-HPLC. Asian J. Pharm. Ana. 2012; 2(3): 85-89.https://ajpaonline.com/AbstractView.aspx?PID=2012-2-3-6
16.    S. J. Daharwal. Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of Diazepam and Propranolol in Bulk Drug and Its Formulations. Asian J. Pharm. Ana. 2013; 3(1): 20-23.https://ajpaonline.com/AbstractView.aspx?PID=2013-3-1-5
17.    KasadPinaz A., K.S. Muralikrishna. Method Development and Acid Degradation Study of Rivaroxaban by RP-HPLC in bulk. Asian J. Pharm. Ana. 2013;3(2): 62-65.doi: 10.5958/2231–5675
18.    RenuSolanki, BadriPrakashNagori, Mahendra Kumar Naval, Joytosh Banerjee. Development and Validation of Simultaneous Estimation Method for AmoxycillinTrihydrate and Tinidazole in Tablet Dosage Form by RP-HPLC. Asian J. Pharm. Ana. 2013;3(2): 66-71.https://ajpaonline.com/AbstractView.aspx?PID=2013-3-2-8
19.    Revathi R., Saravanan V.S., Ethiraj T., Jhansi Lakshmi Marreddy. RP-HPLC Analysis for Quantitation of Candesartan Cilexetil in Solid Dosage Forms. Asian J. Pharm. Ana. 2013;3(4): 115-118.https://ajpaonline.com/AbstractView.aspx?PID=2013-3-4-2
20.    U. S. Department of Health and Human Services, Food, and Drug Administration, Guidance for Industry, Bioanalytical Method Validation, U. S. Department of Health and Human Services, FDA, 2001.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available